chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt recvd Engerix-B on 28FEB92, 20MAR92 & approx 5MAY92; 15MAR92 pt hospitalized for aseptic meningitis w/fever, h/a, back & neck pain & stiffness, nausea, vomiting, sore throat; pt hospitalized x 48 hrs;
I had a fever and I took a home test for COVID-19 on 12/10/2022 and it was positive. I called my son which is a doctor and prescribed Paxlovid. I finished the treatment and I felt better after 3 days of medication. I still have coughing and it bother's me when I am sleeping.
I had a fever and chills. I had trouble breathing. I have asthma. I went to the doctor. They did a chest-ray and a Covid-19, which can back positive.
Sore arm immediately following 2nd covid vaccine on 9/10. Headache started up a few days later and has not gone away.  Terrible 48 hours of chills, aches beginning on 9/19. Had to leave work early.   Improved slightly for a few days and am currently going through another round of chills, aches, and bad headache.   Been unable to do normal activities.  No energy and fatigued.
went for the rapid test/positive/have COVID; went for the rapid test positive/have COVID; No sense of taste or smell; No sense of taste or smell; Coughing; Fatigue extreme; This is a spontaneous report from a contactable consumer. This consumer reported similar events for two patients. This is the second of two reports, reporting for the husband. A male patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 20Jan2021 to 20Jan2021 at single dose for COVID-19 immunization. Medical history included ongoing chronic fatigue syndrome. The patient's concomitant medications were not reported. The patient exhibited a lot of symptoms. And he by the way he complicated things. He got his shot, his first Pfizer shot on 20Jan2021, and then on the 24Jan2021 he left to go to (Name). He came home on the end of the week, he came on Friday. He was coughing and exhibiting extreme fatigue in Jan2021, but he also suffered from chronic fatigue syndrome and other underline situations, so he attributed to that. So he went ahead and they cohabitated and on Sunday the consumer started to get these symptoms. This past Wednesday (03Feb2021) he came to consumer and said he had no sense of taste or smell, and they knew what that meant. So, he immediately went to get a COVID test, but he had to wait. And then in the interim the consumer's situation pretty much stayed rather static, it didn't much change. Then on Thursday (04Feb2021) he said he was going for a rapid test, and consumer said wanted to go too. So, they went ahead and they went to an urgent care and they went for the rapid test and they were both been positive. They both had COVID. The event outcome was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021145196 same reporter/product, different patient, similar event
10 days after receiving the 1st dose of the Pfizer covid vaccine, I started coughing. Within hours, I had a fever of 101.  Body racking coughs, headaches, fevers, exhaustion proceeded to get worse over the next few days.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 46-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Oct2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 46 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Pcn" (unspecified if ongoing), notes: Known allergies: Pcn; "Known allergies: sulfa" (unspecified if ongoing), notes: Known allergies: sulfa. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Vaccine received and No other medication in 2weeks  The information on the batch/lot number for [BNT162B2, BNT162B2 OMI BA.4-5] has been requested and will be submitted if and when received.; Sender's Comments: Based on available information and the temporal association, a possible contributory role of Comirnaty vaccine cannot be excluded for the reported events of  "DRUG INEFFECTIVE " and "COVID 19 ".
Headache, Myalgia, Tachycardia, chills, fatigue Narrative:  Chills, significant fatigue, and headache. Took Ibuprofen OTC every 4 hours. Also noticed a bit of tachycardia a few minutes after she received the vaccine where she was monitored for a while at the vaccine clinic. All symptoms have resolved.
Patient was about 15 weeks pregnant and this was her first pregnancy. Her anticipated due date was Oct 1st 2021. On April 9th 2021 during a scheduled doctor visit at 3pm both baby and mother were in good health.  On the same evening after the appointment she went for vaccination at Pharmacy and received the J&J vaccine. After receiving the vaccine in about 15 mins she felt like urinating and noticed blood in the urine and felt vaginal dilation. Within the next 15 to 20 mins she started experiencing mild labor pains and contractions. In the next 30 mins she started bleeding and was immediately taken to the ER. In the ER it was confirmed that she was having a miscarriage and the fetus was delivered. She also had to undergo emergency surgery to remove any remaining placenta in the uterus.
Hospitalized (9.25.21);  COVID-19 positive (9.25.21);  Fully Vaccinated  HISTORY OF PRESENT ILLNESS: Patient is a 72 y.o. male chronic obstructive pulmonary disease on nightly 2 L O2 nasal cannula, OSA on CPAP, chronic diastolic heart failure, permanent atrial fibrillation on Xarelto, history of B-cell lymphoma (2019), orthostatic hypotension, hyperlipidemia, hypothyroidism and depression who presents upper respiratory symptoms for the past 8 days and worsening dyspnea, subsequently found to be COVID-19 positive.  He was fully vaccinated with Pfizer in February 2021. Symptoms began 8 days ago with rhinorrhea, body aches, fatigue, few episodes of diarrhea, nausea and 1 episode vomiting.  Yesterday, he first noticed increasing shortness of breath and a mildly productive cough. Today, he came to the emergency department when feeling significant dizziness and noticing oxygen was 87% on 2 L nasal cannula.  He had a negative rapid COVID test on 9/20 and was seen at urgent care on 09/23 where he was diagnosed with chronic obstructive pulmonary disease exacerbation along with possible cellulitis due to new, bluish discoloration at the distal aspect of his left foot.  Discolored area is tender to palpation, but patient is unaware of any trauma to the region and is never had similar symptoms.  He was discharged with prednisone and Keflex which is taken for the last 3 days.  No fevers, rigors, chest pain, spreading rash, syncope or history of PE.  He has been compliant with all his medications including Xarelto during this time.  During my exam, patient's heart rate is decreasing to the 30s- 40s briefly before returning to the high 50s.  He is asymptomatic during this.   On arrival to the emergency department, patient's vital signs were unremarkable with exception of SpO2 93% on 4 L nasal cannula.  Heart rate was intermittently dropped to 30s to 40s.  Labs remarkable for calcium 7.2 this, albumin 1.8, procalcitonin 0.07, normal WBC digoxin level 1.0.  COVID-19 a detected.  Chest x-ray shows mild bilateral patchy opacities in a reticular pattern which is mildly increased from prior along with chronic blunting of the left costophrenic angle.  Independent review of EKG shows atrial fibrillation with bradycardia and QTC 423 milliseconds.  He was given dexamethasone 6 mg. Admitted to hospital medicine for acute hypoxic respiratory failure secondary to COVID-19 pneumonia  Acute on chronic hypoxic respiratory failure  COVID-19 pneumonia COPD with baseline oxygen at 2L NC nightly, not exacerbated -Fully vaccinated Pfizer 2/2021 -Symptom onset 8 days ago -Positive test 9/25 -Procalcitonin 0.07, no leukocytosis  -CXR patchy opacities both lungs, only mildly increased from prior lung findings -Check film array -Monitor off antibiotics -Dexamethasone 6 mg daily -Out of window for remdesivir -Continue spiriva and albuterol prn -Maintain O2 sats 88-92%
I started with a sore throat and being tired. I was on vacation so I thought I was tired from the events of the vacation. I completed a COVID-19 test upon the return from the vacation on 04-16. I developed congestion and a cough. I called out from work and retested on 04-17-2022 and was still positive. I continued to have the coughing and congestion. I was cleared on Sunday April 24. My congestion went away and I had a cough that was not too bad so I returned to work. I went to the doctor on April 28, 2022, and at that point I spoke with her about my symptoms. I had emailed the provider previously and she prescribed an albuterol and steroid inhaler. The steroid inhaler was not available until a week later. I also began to take Singulair around the 28th.
Pt 3/29/1961 had a severe reaction after receiving his shingrix vaccine.  He stated feeling light headed, then appeared to lose consciousness and have a seizure for about one to two minutes.  After this episode the patient continued to feel light headed and had broken into a full sweat.  He knew where he was and that he had received a vaccine.  EMS was called and evaluated the patient.  They then took the patient to the hospital for further evaluation.  The patient's partner  called back and stated the hospital said he had Afib, either underlying or brought on by the shingrix vaccine.
Information has been received from a clinic manager (registered nurse) concerning a 19 year old female, who at 13:30 on 27-MAY-2008 received the first dose of ZOSTAVAX (lot#: 659613/0203X) 0.65ml subcutaneoulsy in the right arm instead of the intended dose of varicella virus vaccine live (MSD). There was no product confusion involved. The incident was due to human error. On 25-JUN-2008, the patient returned and stated she had no problems post vaccination. The office has since placed the vaccines in labeled bins in the freezer. Additional information is not expected.
pt recvd vax 15DEC95 later that next noc-red, swollen, & hard, sl pain dec arm (occ); Ibuprofen
measles titer non-immune;measles immun started 16APR99;no documentation of measles immunization or disease prior;rash on chest 30APR99 reported saw Md;felt was rxn to immunization;
Horrible migrainous headache; he also felt tired and fatigued; This is a spontaneous report from a contactable consumer. This consumer (patient) reported that the 34-year-old male patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE), intramuscular, administered in Arm Right on 11Apr2021 15:30 (Batch/Lot Number: EW0151) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient previously took first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE) on 21Mar2021 for covid-19 immunisation. The patient experienced horrible migrainous headache on 11Apr2021 evening with outcome of not recovered, he also felt tired and fatigued on 11Apr2021 15:30PM with outcome of recovered. Therapeutic measures were taken as a result of horrible migrainous headache.  The clinical course was reported as follows: I was having some complications with my vaccine. I received my 2nd vaccination 8 days ago and hours after I got the vaccine I come down with a horrible migrainous headache. It has been 8 days now and it has not subsided. Is it common to last this long? Is it something I should be worried about? Side effects (such as fever, chills, tiredness, and headache) throughout the body were more common after the second dose of the vaccine. Consumer calling states he received the second dose of the Pfizer COVID 19 vaccine last Sunday. Reports a few hours later he had a horrible migraine headache and has had it for eight days now. Adds nothing will stop it, no matter how much Tylenol he takes. Adds he doesn't usually have headaches. Later clarifies it was pharmacy brand acetaminophen he has taken for the migraine. Provides UPS50428317112; lot S210022; expiration date AUG2023 for the acetaminophen. Consumer states he received the first dose of the Pfizer COVID 19 vaccine on 21MAR2021 at 1530PM in the right arm. Then he received the second dose on 11APR2021 at 1530PM in the right arm. By the evening after the second dose he had the headache. Adds he also felt tired and fatigued but he took a nap and that went away. Adds he figured a couple of days is okay but a week is too long and he is worried. He is asking should he be worried; how long before he should go to see a doctor? Advised caller call center does not provide medical advice. Vaccination Facility was pharmacy. No Vaccine Administered at (name) Facility. History of all previous immunization with the Pfizer vaccine considered as suspect was none. Additional Vaccines Administered on Same Date of the Pfizer Suspect was none. No AE(s) require a visit to Emergency Room or Physician Office. Prior Vaccinations (within 4 weeks) was none. Patient's Medical History (including any illness at time of vaccination) was none. Family History was none. Relevant test was none.   No follow-up attempts are needed. No further information is expected
Information has been received from a nurse practitioner concerning a 35 year old white female LPN with asthma and penicillin allergy, who on 12-NOV-2007 was vaccinated in the left deltoid with pneumococcal 23v polysaccharide vaccine (lot # 657529/0993U). There were no illnesses at time of vaccination. On 12-NOV-2007, the patient noticed redness to the injection site with some swelling. On 13-NOV-2007, the patient developed raised confluent hive to the left deltoid and was very painful to the touch. The redness and swelling remained the same, however, the pain was worse and the patient experienced achiness down to the left lower arm. The patient also experienced pain with raising the left arm above the shoulder and decreased range of motion to the left arm and left shoulder. The patient denied numbness or tingling sensation. The patient was treated with a sling to keep the left arm up as much as possible and cephalexin 250 mg, one table four times a day times x10 days, and MEDROL-DOSEPAK. The patient subsequently recovered from the raised confluent hive and decreased range of motion to left arm and left shoulder on 18-NOV-2007. No further information is expected.
20-30 minutes after H1N1 vaccine given in L arm-employee felt dizzy, itchiness in chest and body chest tightness and SOB with rash and wheezing. Went to ER. Given ALBUTEROL treatment, O2, BENADRYL and SOLUMEDROL.
paresthesia of fingers and hands, feet, toes and center of tongue; excessive bleeding and clots during menstruation
My heartrate started to elevate which scared me. I had fatigue, swollen arm. I have shortness of breath. My joints were more achy than normal when I try and walk.  I have expected to be much better than I am by now. I get so fatigued after doing anything now, which was not the case before I got my 4th dose.
Several minutes after the vaccine, I noticed my arm going numb. It progressed up the side of my neck and down to my fingertips. The numbness lasted over an hour.  Extreme nausea vomiting and fatigue started 12 hours later. Which hasn?t yet dissipated. It has now been 34 hours since vaccination.
covid vaccine-related myocarditis/suffering from this; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (005570).  A male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The patient wife called to gain information or research on covid vaccine-related myocarditis. Her husband who is a healthy, young male is suffering from this with an unknown cause. The following information was reported: MYOCARDITIS (medically significant), outcome "unknown", described as "covid vaccine-related myocarditis/suffering from this".  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
This case was reported by a healthcare professional (certified medical assistant) and described the occurrence of injection site pain in a 49-year-old female subject who was vaccinated with BOOSTRIX (GlaxoSmithKline). Concurrent medical conditions included arthritis, bursitis, hypercholesterolemia and low back pain. Concurrent medications included amlodipine, liothyronine, multivitamins, FLONASE, ALLEGRA and SYNTHROID. On 17 January 2014 at 12:00 the subject received a dose of BOOSTRIX (.5 ml, intramuscular, left deltoid). On 17 January 2014, immediately after vaccination with BOOSTRIX, the subject experienced injection site pain (described as "achiness in her left arm") and injection site discomfort (described as constantly switching and repositioning arm). Per the pharmacist, the subject took EXCEDRIN and ibuprofen as treatment but they did not help and the achiness has worsened. Per the pharmacist, "because of her arm throbbing and aching, the [subject] has to constantly switch and reposition her arm." The pharmacist reported that, in January 2014, the subject described injection site pain as "radiating down to her left scapula." In January of 2014, weeks after vaccination with BOOSTRIX, the subject experienced worsening of bursitis and arthritis aggravated. The pharmacist stated that the subject "now says her bursitis and arthritis have been exacerbated." According to the pharmacist at the time of reporting, medical attention was not required. The subject was treated with EXCEDRIN and ibuprofen. At the time of reporting the events were worse. Follow-up information received on 19 February 2014 via medical assistant. Additional medical conditions included hypertension and chronic lymphocytic thyroiditis. The medical assistant reported the subject's diagnosis was acute shoulder pain. The onset of the events was clarified to be 28 January 2014. The medical assistant associated the events with the subject's medical history/ concurrent illness of left shoulder arthritis. No action was taken with BOOSTRIX. The reporting healthcare professional did not consider the events to be serious. At the time of the report the events were reported to be improved.
5/2/13 Mom called to report 4" area of redness and warmth. 5/3/13 per mom, school nurse said it is no longer swollen, child says it feels better.
Information has been received from a registered nurse concerning a 65 year old female with hypothyroidism, osteoporosis and a history of headaches from antihistamines who on 27-APR-2007 was vaccinated with Recombivax HB.  On that same day, the patient was also vaccinated with Td (MSD), Fluvirin (unspecified), YF-Vax, typhoid vaccine live oral (Ty21a).  Concomitant therapy included thyroid medication and EVISTA.  On 29-MAY-2007, the patient had a follow-up doctor visit  and stated that on approximately 04-MAY-2007 she experienced dizziness and vertigo.  The patient was referred for follow-up to an ear, nose and throat physician and eye doctor.  Subsequently, the patient recovered from dizziness and vertigo.  Additional information has been requested.  Follow-up information has been received from a registered nurse concerning a 66 year old female with hypothyroidism, osteoporosis and a history of headaches from antihistamines who on 27-APR-2007 was vaccinated with her first IM dose of Recombivax HB (Lot# 655810/1022F) at 11:00 in the left deltoid.  Concomitant vaccinations administered on that same day at 11:00 included first dose of IM Td (Lot# TD-165) in the right deltoid, the first dose of IM Vaqta (MSD) (Lot# 652507/0886R) in the right deltoid, the first dose of Fluvirin (unspecified) (Lot# 71213) in the left deltoid, the first dose of SC YF-Vax (Lot# UF044AA) in the right deltoid, and 4 capsules of typhoid vaccine live oral (Ty21a) (Lot# 3001173).  Other concomitant drug therapy included thyroid medication and EVISTA.  On 04-MAY-2007 the patient felt like the room would spin while lying down.  The patient was referred for follow-up to an ear, nose and throat physician.  Subsequently, the patient recovered.  On 02-JUN-2007, the patient reported that she was found to have "an inner ear problem."  On 02-JUN-2007 the patient was administered her second dose of Recombivax HB.  No problems were reported.  Additional information has been requested.
On day after vaccination, developed red area size of dime at injection site, continuously grew to two inch diameter circle, swollen and hot to touch, lasting over a week, extremely tender and painful wincing to touch, appears like a cellulitis. Injection technique unknown to this writer. As of this event report, area is still tender to touch and slight swelled but swelling markedly improved and redness nearly gone. Slight faded bruising noticeable. Patient is clearly more tired, unclear if attributable to pregnancy or vaccine or combination, has become more intolerant to cold, describes overall achiness. Never any fever over course.  Est date of pregnancy delivery Oct 6, 2021.
Patient, age 101, was having a period of declining health prior to vaccine administration.  This continued after the vaccine to include increased pain, inability to swallow and ultimately Patient passed away on 1/9/2021.  The physician does not believe this is due to vaccine administration, however family asked that this information be reported for record keeping.
pt exp soreness, erythema, & swelling @ the inject site p/receiving flu vax;
C/o throat closing up, dizziness, headache soon after 2nd dose Moderna. Pt took a puff of her inhalant & felt relieve. All vitals wnl.
administered vaccine reconstituted with sterile water; administered vaccine reconstituted with sterile water; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 12-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMAA602A, expiry date 31st August 2022) for prophylaxis.   On 24th February 2022, the patient received Menveo. On 24th February 2022, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 31-MAR-2022 Reporter's Comments:  Medical Assistant reported that, the patient received vaccine which was reconstituted with sterile water instead of the supplied CYW-135 liquid diluent, which led Inappropriate preparation of medication and Inappropriate dose of vaccine administered The reporter consented to follow up.